Literature DB >> 35624180

Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration.

Taiki Moriya1,2, Mayuko Hashimoto1, Hina Matsushita1, Shion Masuyama1, Rina Yoshida1, Ryuhei Okada3, Aki Furusawa3, Daiki Fujimura3, Hiroaki Wakiyama3, Takuya Kato3, Peter L Choyke3, Yutaka Kusumoto1, Tatyana Chtanova4,5, Hisataka Kobayashi3, Michio Tomura6.   

Abstract

Near-infrared photoimmunotherapy (NIR-PIT) selectively kills tumor cells to which the photo-absorber dye IR700DX-conjugated antibodies are bound and induces a systemic anti-tumor immune response. NIR-PIT induces immunogenic cell death (ICD), releases damage-associated molecular patterns (DAMPs) molecules from dying tumor cells, and activates dendritic cells (DCs). However, it is unclear whether NIR-PIT affects migration of tumor-infiltrating (Ti)-DCs to draining lymph nodes (dLNs), where a systemic anti-tumor response is induced. Here, we utilized in vivo photolabeling of Ti-DCs in tumors in photoconvertible protein Kikume Green-Red (KikGR) mice to show that NIR-PIT enhanced migration of Ti-DCs including cDC1s, cDC2s, and CD326+ DCs to dLNs. This effect was abolished by blocking adenosine triphosphate (ATP), one of the DAMPs molecules, as well as by inhibition of Gαi signaling by pertussis toxin. Thus, ICD induction by NIR-PIT stimulates Ti-DC migration to dLNs via ATP-P2X7 receptor and Gαi protein-coupled receptor signaling pathways and may augment tumor antigen presentation to induce anti-tumor T cells in dLNs.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cellular migration; Immunogenic cell death; Near-infrared photoimmunotherapy; Photo labeling; Tumor; Tumor-infiltrating dendritic cells

Year:  2022        PMID: 35624180     DOI: 10.1007/s00262-022-03216-2

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.630


  14 in total

1.  Tracking the fate and migration of cells in live animals with cell-cycle indicators and photoconvertible proteins.

Authors:  Michio Tomura; Ryoyo Ikebuchi; Taiki Moriya; Yutaka Kusumoto
Journal:  J Neurosci Methods       Date:  2021-03-17       Impact factor: 2.390

2.  In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors.

Authors:  Tommaso Torcellan; Henry R Hampton; Jacqueline Bailey; Michio Tomura; Robert Brink; Tatyana Chtanova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

3.  Cutting Edge: Recruitment, Retention, and Migration Underpin Functional Phenotypic Heterogeneity of Regulatory T Cells in Tumors.

Authors:  Ryoyo Ikebuchi; Taiki Moriya; Mizuki Ueda; Ippei Yasuda; Yutaka Kusumoto; Tatyana Chtanova; Michio Tomura
Journal:  J Immunol       Date:  2021-07-21       Impact factor: 5.422

Review 4.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

5.  In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

Authors:  P J Spiess; J C Yang; S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

6.  Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors.

Authors:  Tadanobu Nagaya; Jay Friedman; Yasuhiro Maruoka; Fusa Ogata; Shuhei Okuyama; Paul E Clavijo; Peter L Choyke; Clint Allen; Hisataka Kobayashi
Journal:  Cancer Immunol Res       Date:  2019-01-25       Impact factor: 11.151

7.  Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.

Authors:  Edward W Roberts; Miranda L Broz; Mikhail Binnewies; Mark B Headley; Amanda E Nelson; Denise M Wolf; Tsuneyasu Kaisho; Dusan Bogunovic; Nina Bhardwaj; Matthew F Krummel
Journal:  Cancer Cell       Date:  2016-07-14       Impact factor: 31.743

8.  Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.

Authors:  Hisataka Kobayashi; Aki Furusawa; Adrian Rosenberg; Peter L Choyke
Journal:  Int Immunol       Date:  2021-01-01       Impact factor: 4.823

9.  Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.

Authors:  Makoto Mitsunaga; Mikako Ogawa; Nobuyuki Kosaka; Lauren T Rosenblum; Peter L Choyke; Hisataka Kobayashi
Journal:  Nat Med       Date:  2011-11-06       Impact factor: 53.440

10.  Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity.

Authors:  Taiki Moriya; Kurumi Kitagawa; Yuuki Hayakawa; Hiroaki Hemmi; Tsuneyasu Kaisho; Satoshi Ueha; Ryoyo Ikebuchi; Ippei Yasuda; Yasutaka Nakanishi; Tetsuya Honda; Koji Matsushima; Kenji Kabashima; Mizuki Ueda; Yutaka Kusumoto; Tatyana Chtanova; Michio Tomura
Journal:  iScience       Date:  2021-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.